Clinical trials play a pivotal role in advancing medical research and developing innovative treatments. Singapore has emerged as a leading hub for clinical trials, with over 5,000 ongoing studies across diverse therapeutic areas.
Numerous resources are available to help patients and researchers locate clinical trials in Singapore:
Therapeutic Area | Number of Trials |
---|---|
Oncology | 1,500+ |
Immunology | 500+ |
Infectious Diseases | 350+ |
Cardiovascular | 250+ |
Neurology | 200+ |
Clinical trials in Singapore encompass various phases:
Phase | Duration | Number of Participants | Purpose |
---|---|---|---|
Phase I | 1-2 years | 20-100 | Safety and tolerability |
Phase II | 2-5 years | 100-500 | Efficacy and safety |
Phase III | 5-8 years | 1,000-3,000 | Comparative effectiveness |
Phase IV | Indefinite | Varies | Long-term safety and effectiveness |
Pros:
Cons:
Title | Therapeutic Area | Lead Institution | Status |
---|---|---|---|
TESAR: A Study of the Efficacy and Safety of Tesarotene in Patients with Advanced Epithelial Ovarian Cancer | Oncology | National Cancer Centre Singapore | Phase III |
BRAVE: A Phase III Study of BGB-3111 in Combination with Azacitidine in Patients with Newly Diagnosed Acute Myeloid Leukemia | Oncology | National University Cancer Institute, Singapore | Phase III |
SPIRIT: A Randomized, Controlled Trial of Small Pox Vaccine (SPV) for the Prevention of Monkeypox in Singapore | Infectious Diseases | Singapore General Hospital | Phase III |
ASCEND-LV: A Study to Evaluate the Safety and Efficacy of Sacubitril/Valsartan in Subjects with Symptomatic Chronic Heart Failure with Reduced Ejection Fraction | Cardiovascular | National Heart Centre Singapore | Phase IV |
ADagio: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Gimycin in Adults Hospitalized with COVID-19 | Infectious Diseases | National Centre for Infectious Diseases | Phase III |
Source | Funding Amount |
---|---|
Government (Ministry of Health) | S$50 million per year |
National Healthcare Group | S$20 million per year |
Singapore General Hospital | S$10 million per year |
National Cancer Centre Singapore | S$10 million per year |
Industry Partnerships | S$5 million per year |
International Collaboration Grants | S$3 million per year |
Clinical trials in Singapore play a vital role in medical innovation and patient care. With over 5,000 ongoing studies, Singapore offers a dynamic and research
2024-11-17 01:53:44 UTC
2024-11-18 01:53:44 UTC
2024-11-19 01:53:51 UTC
2024-08-01 02:38:21 UTC
2024-07-18 07:41:36 UTC
2024-12-23 02:02:18 UTC
2024-11-16 01:53:42 UTC
2024-12-22 02:02:12 UTC
2024-12-20 02:02:07 UTC
2024-11-20 01:53:51 UTC
2024-10-25 21:21:08 UTC
2024-10-26 11:27:20 UTC
2024-10-27 01:45:07 UTC
2024-10-27 15:27:58 UTC
2024-10-28 21:20:16 UTC
2024-10-29 13:37:09 UTC
2024-10-30 06:03:06 UTC
2024-10-31 15:06:30 UTC
2025-01-06 06:15:39 UTC
2025-01-06 06:15:38 UTC
2025-01-06 06:15:38 UTC
2025-01-06 06:15:38 UTC
2025-01-06 06:15:37 UTC
2025-01-06 06:15:37 UTC
2025-01-06 06:15:33 UTC
2025-01-06 06:15:33 UTC